Skip to main content

Table 1 Main characteristics of the studies included in the meta-analysis

From: The prognostic value of lncRNA SNHG6 in cancer patients

Authors

Year

Cancer

HR (95% CI)

Method

No.

Follow

NOS

An et al.

2018

RCC

1.93 (1.23–3.05)

RT-PCR

81

80 m

9

Li et al.

2018

CRC

2.57 (1.06–6.25)

RT-PCR

74

NR

8

Meng et al.

2018

Glioma

1.65 (1.10–3.32)

RT-PCR

71

60 m

9

Xu et al.

2019

CRC

2.48 (1.60–5.86)

RT-PCR

120

NR

8

Yu et al.

2019

CRC

2.83 (1.20–8.36)

RT-PCR

141

NR

8

  1. RCC renal cell carcinoma, CRC colorectal cancer, HR hazard ratio, 95% CI 95% confidence interval, NR no report